Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Non-Current Assets (2018 - 2025)

Dna X (SONM) has disclosed Non-Current Assets for 8 consecutive years, with $9.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-Current Assets fell 35.1% year-over-year to $9.9 million, compared with a TTM value of $35.5 million through Sep 2025, down 33.91%, and an annual FY2024 reading of $7.6 million, down 38.2% over the prior year.
  • Non-Current Assets was $9.9 million for Q3 2025 at Dna X, up from $9.0 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $15.3 million in Q3 2024 and bottomed at $2.4 million in Q4 2021.
  • Average Non-Current Assets over 5 years is $8.5 million, with a median of $9.0 million recorded in 2025.
  • The sharpest move saw Non-Current Assets skyrocketed 410.31% in 2021, then crashed 38.2% in 2024.
  • Year by year, Non-Current Assets stood at $2.4 million in 2021, then surged by 189.49% to $6.9 million in 2022, then soared by 78.63% to $12.3 million in 2023, then plummeted by 38.2% to $7.6 million in 2024, then soared by 30.95% to $9.9 million in 2025.
  • Business Quant data shows Non-Current Assets for SONM at $9.9 million in Q3 2025, $9.0 million in Q2 2025, and $9.0 million in Q1 2025.